Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

5.13

+0.04 (0.79%)

At close: May 14, 2026

EGX:RMDA Cash Flow Statement

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	298.46	387.37	244.86	245.68	181.09
Depreciation & Amortization	92.23	83.43	72.88	65.48	46.18
Loss (Gain) From Sale of Assets	-0.15	-0.01	-0.14	0.13	0.72
Asset Writedown & Restructuring Costs	2.56	2.51	-	-	-
Stock-Based Compensation	15.95	16.29	17.77	17.85	-
Provision & Write-off of Bad Debts	104.8	11.44	3.81	3.64	0.11
Other Operating Activities	60.94	9.24	2.42	-8.44	-10.39
Change in Accounts Receivable	-741.17	-218.62	-374.86	-243.64	-29.45
Change in Inventory	-273.6	-439.51	30.97	-88.59	47.58
Change in Accounts Payable	52.98	276.38	16.97	68.59	31.51
Change in Other Net Operating Assets	343.33	-435.45	-59.17	-31.35	-25.99
Operating Cash Flow	-43.67	-306.92	-44.5	29.35	241.35
Operating Cash Flow Growth	-	-	-	-87.84%	-
Capital Expenditures	-155.9	-64.93	-91.05	-34.38	-52.67
Sale of Property, Plant & Equipment	0.2	1.72	0.18	0.02	0.02
Sale (Purchase) of Intangibles	-594.95	-1.71	-162.44	-93.9	-185.53
Investment in Securities	237.39	120.66	194.68	167.47	68.06
Other Investing Activities	-	-93.84	-	-	-
Investing Cash Flow	-513.26	-38.09	-58.63	39.22	-170.11
Short-Term Debt Issued	3,434	1,998	1,421	1,205	1,172
Total Debt Issued	3,434	1,998	1,421	1,205	1,172
Short-Term Debt Repaid	-2,681	-1,551	-1,265	-1,121	-1,156
Long-Term Debt Repaid	-13.25	-6.34	-5.74	-27.14	-71.19
Total Debt Repaid	-2,694	-1,558	-1,271	-1,149	-1,228
Net Debt Issued (Repaid)	740.47	440.9	149.72	56.96	-55.09
Issuance of Common Stock	1.88	3.23	2.11	-	-
Repurchase of Common Stock	-	-	-	-65.93	-
Common Dividends Paid	-188.91	-121.28	-16.76	-24.31	-14.7
Financing Cash Flow	553.44	322.86	135.07	-33.28	-69.79
Foreign Exchange Rate Adjustments	-24.82	34.48	0.42	17.22	-0.19
Net Cash Flow	-28.32	12.32	32.37	52.51	1.26
Free Cash Flow	-199.57	-371.85	-135.54	-5.03	188.68
Free Cash Flow Margin	-4.87%	-13.43%	-7.05%	-0.34%	15.14%
Free Cash Flow Per Share	-0.10	-0.18	-0.07	-0.00	0.09
Cash Interest Paid	526.8	294.66	186.52	84.82	89.41
Cash Income Tax Paid	101.81	67.07	60.69	44.29	28.91
Levered Free Cash Flow	-834.46	-552.55	-381.77	-108.98	-7.86
Unlevered Free Cash Flow	-502.42	-360.54	-262.27	-53.32	49.03
Change in Working Capital	-618.46	-817.2	-386.09	-295	23.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.